Dapsone-mediated agranulocytosis: Risks, possible mechanisms and prevention

Toxicology

Volumn 162, Issue 1, 2001, Pages 53-60

  Coleman, Michael D ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Agranulocytosis; Idiosyncratic reaction; Neutrophil

Indexed keywords

AMINOPHENAZONE; ANTITHYROID AGENT; CLOZAPINE; DAPSONE; DIPYRONE; MALOPRIM; SULFONAMIDE;

ACNE; AGRANULOCYTOSIS; ARTICLE; CELIAC DISEASE; CLINICAL FEATURE; DERMATITIS HERPETIFORMIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INCIDENCE; LEPROSY; LEUKOCYTE COUNT; MALARIA; PRIORITY JOURNAL; RACE DIFFERENCE;

AGRANULOCYTOSIS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIMALARIALS; DAPSONE; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRIMETHAMINE;

EID: 0035848971     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(01)00360-2     Document Type: Article

References (50)

1. A dapsone-induced blood dyscrasia in the mouse: Evidence for the role of an active metabolite
2. Agranulocytosis: Incidence and risk factors
3. Do white cell spikes predict agranulocytosis in clozapine recipients?
4. Aetiology of severe aplastic anaemia and outcome after allogenic bonemarrow transplantation of immunosuppression therapy
5. Dapsone suppresses integrin-mediated neutrophil adherance function
6. Dapsone induced agranulocytosis: Spontaneous reporting data
7. Bioactivation of dapsone into a cytotoxic by human hepatic microsomal enzymes
8. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man
9. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients
10. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in virto IV: The role of the erythrocyte in the development of dapsone-dependent agranulocytosis
11. Dapsone toxicity: Some current perspectives
12. Preliminary evaluation of the toxicity and efficacy of novel 2,4 diamino 5-benzyl pyrimidine-sulphone derivatives using rat and human tissues in vitro
13. Studies on the anti-inflammatory effects of novel analogues of dapsone in vitro
14. Anti-inflammatory action of dapsone: Inhibition of neutrophil adherance is associated with inhibition of chemoattractant-induced signal transduction
15. Linear IgA disease with haemorrhagic pompholyx and dapsone-induced neutropenia
16. Examination of possible toxic and immune mechanisms of clozapine-induced agranulocytosis
17. Incidence and presentation of coeliac disease in South Glamorgan
18. Pharmacokinetic profiles in rats after intravenous. Oral or dermal administration of dapsone
19. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988
20. Clozapine and agranulocytosis
21. Incidence and non-drug aetiologies of aplastic anaemia in Thailand
22. Rapid progression of chronicmyelomonocytic leukemia following diaminodiphenyl sulphone treatment for dermatitis herpetiformis
23. Drugs in the aetiology of agranulocytosis and aplastic anaemia
24. Mechanism of inhibition of myeloperoxidase by anti-inflammatory drugs
25. Superoxide is an antagonist of anti-inflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase
26. Dapsone-induced agranulocytosis in a case of dermatitis herpetiformis
27. The etiology of primary granulopenic (agranulocyte angina)
28. A fatal complication of clozapine-induced agranulocytosis
29. Agranulocytosis due to the occurrence of leukocyte-agglutinins
30. Agranulocytosis due to dapsone
31. Drug disposition and drug hypersensitivity
32. Propylthiouracil-induced immune-mediated disease in the cat
33. Dapsone-induced neutropenia in patients treated for ocular cicatricial pemphigoid
34. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: Incidence and associations with antecedent prescription drug use
35. Rechallenge in clozapine-induced agranulocytosis
36. Agranulocytosis in Bangkok, Thailand: A prodeominantly drug-induced disease with an unusually low incidence
37. Descriptive epidemiology of agranulocytosis
38. Pharmacokinetic observations on dapsone in dermatitis herpetiformis
39. Risks of agranulcytosis and aplastic anemia: A first report of their relation to drug use with special reference to analgesics
40. Metabolism of dapsone to a hydroxylamine by human neutrophils and mononuclear cells
41. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions
42. N-chlorination of sulfamethazole and dapsone by the myeloperoxidase system
43. Reactive metabolites and agranulocytosis
44. Current trends in drug-induced autoimmunity
45. In vitro inhibition of granulopoiesis by 4 amino 4′ hydroxylamino phenyl sulphone
46. Drug related blood dyscrasias in a Swedish reporting system, 1985-1994
47. Dapsone hydroxylamine inhibits the LTB4-induced chemotaxis of polymorphonuclear leukocytes into human skin: Results of s pilot study
48. Dermatitis herpetiformis
49. Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system